Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer

Overview of attention for article published in Frontiers in immunology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 76,134 followers.

RT @exosome: There are good macrophages and bad macrophages depending on context...in #cancer you do not want M2 macrophages since they pro…

22 Dec 2022

Reply Repost Favourite

There are good macrophages and bad macrophages depending on context...in #cancer you do not want M2 macrophages since they promote tumor growth M2 macrophages have the molecule TIM-3 Tim3 is also on #cancer stem cells https://t.co/R7lXqUYKhe

22 Dec 2022

Reply Repost Favourite

Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer https://t.co/d7Z9PqdAOh https://t.co/YL5EA40VFL

02 Nov 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer: Lung cancer is…

02 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.